Search clinical trials for: Ibrutinib ofatumumab
Total 520 results
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMantle Cell Lymphoma RefractoryAustralia
-
Theodore S. JohnsonAugusta UniversityRecruitingGlioblastoma | Ependymoma | Medulloblastoma | Primary Brain TumorUnited States
-
M.D. Anderson Cancer CenterRecruitingChronic Lymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstitutePharmacyclics LLC.; The Leukemia and Lymphoma Society; Blood Cancer Research...Active, not recruitingLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterPharmacyclics LLC.Active, not recruitingPrimary Central Nervous System Lymphoma (PCNSL) | Secondary Central Nervous System Lymphoma (SCNSL)United States
-
C. Babis AndreadisGlaxoSmithKline; University of California, San FranciscoCompletedDiffuse Large Cell Lymphoma Relapsed/RefractoryUnited States
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Germany, Hungary, Poland, Portugal, Russian Federation, Slovakia, Spain, Denmark, France, Japan, Israel, Taiwan, Turkey, Czechia, Argentina, Estonia, United Kingdom, India, C... and more
-
Margaret TemperoStand Up To Cancer; Lustgarten FoundationCompletedIbrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic CancerMetastatic Pancreatic AdenocarcinomaUnited States
-
Pharmacyclics LLC.CompletedMetastatic Pancreatic AdenocarcinomaSpain, Italy, Korea, Republic of, United States, Belgium, United Kingdom, Germany, France
-
M.D. Anderson Cancer CenterActive, not recruitingChronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Janssen Research & Development, LLCCompleted
-
Jennifer WoyachActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Central Nervous System Lymphoma | Central Nervous System B-Cell Non-Hodgkin Lymphoma | Recurrent Central Nervous System LymphomaUnited States
-
Merck Sharp & Dohme LLCCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Richter Syndrome | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Loss of Chromosome 17pUnited States
-
AmgenCompletedSarcoma | Soft Tissue Sarcoma | Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma
-
Joseph TuscanoNational Cancer Institute (NCI); Genentech, Inc.; Pharmacyclics LLC.RecruitingAnn Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
M.D. Anderson Cancer CenterNovartisCompleted
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Malignant Solid NeoplasmUnited States
-
Meirav Kedmi MDJohnson & JohnsonUnknownDiffuse Large B Cell Lymphoma | Recurrent Disease | Refractory Cancer | Primary Mediastinal (Thymic) Large B-cell Lymphoma | Transformed Indolent LymphomaIsrael
-
Pharmacyclics LLC.Celgene CorporationTerminatedMultiple MyelomaUnited States, Spain, Australia, Czechia, Germany, Greece
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); A... and other collaboratorsRecruitingDiabetes Mellitus, Type 2 | Impaired Glucose Tolerance (IGT) | Impaired Fasting Glucose (IFG)United States
-
Alliance Foundation Trials, LLC.Pharmacyclics LLC.Active, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Eli Lilly and CompanyCompletedHypercholesterolemiaPoland, Netherlands, United States, Denmark, Canada, Japan, Czechia, Puerto Rico
-
Nanjing University School of MedicineRecruiting
-
Dana-Farber Cancer InstituteGlaxoSmithKline; National Comprehensive Cancer NetworkTerminatedCLL | SLLUnited States
-
Merck Sharp & Dohme LLCTerminatedPostmenopausal Osteoporosis
-
Johns Hopkins UniversityPatient-Centered Outcomes Research Institute; National Multiple Sclerosis SocietyRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
AmgenCompletedMetastatic Colorectal Cancer | Colorectal Cancer | Rectal Cancer | Colon CancerUnited States
-
Emory UniversityNational Cancer Institute (NCI); AstraZenecaRecruitingMantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Lymphoproliferative Disorder | Indolent Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingLymphoma, Mantle-CellTaiwan, Thailand, Malaysia, India, Puerto Rico, Spain, Turkey, Czechia, Brazil, Greece, Poland, Sweden, Romania
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma and other conditionsUnited States
-
Huiqiang HuangXian-Janssen Pharmaceutical Ltd.; Nanfang Hospital of Southern Medical University and other collaboratorsRecruitingPrimary Central Nervous System Lymphoma | Non Hodgkin Lymphoma | PCNSLChina
-
M.D. Anderson Cancer CenterActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Richter Syndrome | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
M.D. Anderson Cancer CenterAmgenTerminatedHematopoietic/Lymphoid Cancer | Richter's TransformationUnited States
-
Kerry RogersActive, not recruitingChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Pharmacyclics LLC.CompletedMetastatic Renal Cell Carcinoma | Metastatic Colorectal Adenocarcinoma | Advanced Gastric Adenocarcinoma | Advanced Urothelial CarcinomaUnited States, Korea, Republic of, Spain, United Kingdom
-
Millennium Pharmaceuticals, Inc.TerminatedLymphoma, Non-HodgkinUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingPrimary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS) | Aggressive B-cell Lymphoma With Secondary Involvement of the CNSUnited States
-
Sumitomo Pharma America, Inc.CompletedHematologic MalignancyUnited States
-
The Cleveland ClinicUniversity of NottinghamActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom
-
CelgeneCompletedLymphoma | Leukemia, Lymphocytic, Chronic, B-CellUnited States, United Kingdom, Germany, France, Italy, Netherlands, Japan
-
Canadian Cancer Trials GroupJanssen Inc.RecruitingNon-hodgkin LymphomaCanada
-
National Cancer Institute (NCI)RecruitingLymphoma | Diffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell LymphomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingWaldenstrom Macroglobulinemia | Recurrent Waldenstrom Macroglobulinemia | Refractory Waldenstrom MacroglobulinemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell Neoplasm
-
Grupo Español de Linfomas y Transplante Autólogo...Janssen-Cilag, S.A.UnknownDiffuse Large B-Cell LymphomaSpain
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; Celgene CorporationActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; Celgene CorporationCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States